Moc-L-Tert-Leucine CAS 162537-11-3 Puritas ≥99.0% (HPLC) Atazanavir Factory medium

Description:

Nomen chemicum: Moc-L-Tert-Leucine

CAS: 162537-11-3

Aspectus: Alba ad Off-White Crystal

Puritas: ≥99.0% (HPLC)

Intermedia Atazanavir HIV-1 Protease Inhibitor

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Manufacturer Supple cum High puritate et stabulo Quality
Nomen chemicum: Moc-L-Tert-Leucine
CAS: 162537-11-3
Intermedia Atazanavir HIV-1 Protease Inhibitor
High Quality, Commercial Production

Chemical Properties:

Nomen chemicum Moc-L-Tert-Leucine
Synonyma Methoxycarbonyl-L-tert-Leucine;N-(Methoxycarbonyl)-tert-Leucine;Atazanavir Related Compone A
CAS Number 162537-11-3
CATTUS Number RF-PI289
Stock Status In Stock, Productio Ascendite ad Tons
Formulae hypotheticae C8H15NO4
M. Pondus 189.21
Liquescens punctum 109℃
Density 1.126 g/cm3
Ferveret 320.9℃ ad 760 mmHg
Solubilitas Solutum in Ethyl acetate et Methanol
Shipping Condition Uit sub Ambient Temperature
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus White ad Off-White Crystal
Lepidium sativum Methodi HPLC
Puritas / Analysis Methodo ≥99.0% (HPLC)
Moc-L-Tle-Tle-OH ≤0.30%
L-Moc-Dimer ≤0.30%
L-Tle-OH ≤0.10%
Methoxycarbonyl-L-Valine ≤0.10%
N-Acetyl-L-tert-Leucine ≤0.05%
Singula Unkown Impuritas ≤0.30%
Totalis immunditias ≤1.0%
Enantiomer Content ≤0.10% (Per Chiral HPLC)
Aqua Content ≤0.50% (By KF)
Damnum in Siccatio ≤0.50%
Residere in Ignition ≤0.20%
Metalla gravis ≤10ppm
Consuetudinem Amino acid;Medium Atazanavir (CAS 198904-31-3);

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Lucem protege, humorem.

commoda:

1

FAQ:

Applicatio:

Shanghai Ruifu Chemical Co., Ltd. est primarium fabricae et supplementi Moc-L-Tert-Leucine (CAS 162537-11-3) magna qualitate.MOC-L-Tert-Leucine est genus acidum amino derivativum.Intermedium utilissimum est ad efficientem synthesim HIV protease inhibitoris Atazanavir (CAS 198904-31-3) necnon Atazanavir sulphate (CAS 229975-97-7).

Atazanavir est agens antiretrovirale quod FDA probatum est usui in compositione cum aliis anti-RTagentis ad curationem infectionis HIV.Medicamentum in inhibitoribus RT coniunctum semper adhibetur.Atazanavir inhibitor est protease HIV-1 (EC50=2.6 nM).In cellulis separatis, effectus antivirales mediocriter synergisticos additivos habet cum aliis medicamentis antiretroviralibus coniunctos.Quam ob rem communiter in vivo in compositione curationis HIV-1 infectio adhibetur.

Epistulam tuam hic scribe et mitte nobis